ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation in Vivo

Ma, Peilin; Huang, JiaYing; Liu, Jinling; Zhu, Yi; Cheng, Jiahong; Cheng, Junming; Lei, Lunwen; Guan, Ziyun; Ban, Junfeng*; Lu, Zhufen*广东药学院; 6
American Journal of Cancer Research2023DOI: 10.7150/jca.82410
13阅读
引用收藏
分享

摘要

Background: Improving the aggregation and penetration in tumor sites increases the anti-tumor efficacy of nanomedicine. In the current study, we designed cyclodextrin modified PLGA nanoparticles loaded with paclitaxel to elevate the accumulation and prolong circulation of chemotherapy drugs in vivo.Methods: The PLGA nanoparticles loaded with paclitaxel (PTX PLGA NPs) and cyclodextrin (CD) modified PLGA nanoparticles loaded with paclitaxel (PTX PLGA/CD NPs) were prepared using the emulsification solvent evaporation method. The nanoparticles were characterized by particle size, zeta potential, encapsulation efficiency, infrared spectroscopy analysis and X-Ray diffraction (XRD). Then, drug release of the nanoparticles was evaluated via reverse dialysis method in vitro. Finally, the in vivo distribution fate and pharmacokinetic characteristics of the nanoparticles were assessed in mice and rats. Results: The average particle size, zeta potential, and encapsulation efficiency of PTX PLGA NPs were (163.57 +/- 2.07) nm, -(20.53 +/- 2.79) mV and (60.44 +/- 6.80)%. The average particle size, zeta potential, and encapsulation efficiency of PTX PLGA/CD NPs were (148.57 +/- 1.66) nm, -(11.42 +/- 0.84) mV and (85.70 +/- 2.06)%. In vitro release studies showed that PTX PLGA/CD NPs were released more slowly compared to PTX PLGA NPs under normal blood pH conditions, while PTX PLGA/CD NPs were released more completely under tumor site pH conditions. The modified PLGA nanocarrier (PLGA/CD NPs) increased drug residence time and accumulation than the plain PLGA nanocarrier (PLGA NPs) in vivo distribution. In addition, the elimination half-life, area under the drug-time curve, and maximum blood concentration of the nanoparticle group were higher than those of Taxol (R), especially the PTX PLGA/CD NPs group, which was significantly different from Taxol (R) and plain nanoparticle groups (p<0.001).Conclusions: The 2-HP-beta-CD modified PLGA nanoparticles prolonged circulation time and accumulation of the chemotherapy drug paclitaxel in vivo.

学科与关键词

关键词
PLGA nanoparticles2-HP-?-CDin vivo imagingpharmacokinetics
相关
加载中…
  • In Vitro/In Vivo Preparation and Evaluation of cRGDyK Peptide-Modified Polydopamine-Bridged Paclitaxel-Loaded Nanoparticles
    Yun, Dan; Liu, Dengyuan; Liu, Jinlin; Feng, Yanyi; Chen, Hongyu; Chen, Simiao; Xie, Qingchun*Pharmaceutics, 2023, 15(11): 2644.
  • Preparation and Characterization of Paclitaxel Loaded SF/PLLA-PEG-PLLA Nanoparticles via Solution-Enhanced Dispersion by Supercritical CO2
    Zhao Zheng; Li Yi*; Zhang YuJournal of Nanomaterials, 2015, 913254.
  • PLGA纳米粒抗肿瘤药物载体的研究进展
    李方园; 姜永莉; 成颖西北药学杂志, 2013, (06): 656-660.
查看全部 →

发表信息

论文状态
公开发表
期刊
American Journal of Cancer Research
发表日期
2023
卷期
第 14 卷, 第 5 期
页码
759-769
DOI
10.7150/jca.82410
语言
ENGLISH
成果收录
SCIE
资助标注
Joint Funds of Natural Science Foundation of Guangdong Province [2021B1515120053]

作者

  • M

    Ma, Peilin (第一作者)

    guangdong pharmaceut univ

  • H

    Huang, JiaYing

    guangdong pharmaceut univ

查看全部 10 位作者收起作者
  • L

    Liu, Jinling

    guangdong pharmaceut univ

  • Z

    Zhu, Yi

    guangdong pharmaceut univ

  • C

    Cheng, Jiahong

    guangdong pharmaceut univ

  • C

    Cheng, Junming

    guangdong pharmaceut univ

  • L

    Lei, Lunwen

    6

  • G

    Guan, Ziyun

    6

  • B

    Ban, Junfeng (通讯)

    guangdong pharmaceut univ

  • L

    Lu, Zhufen (通讯)

    guangdong pharmaceut univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417